Analysts Set The Beauty Health Company (NASDAQ:SKIN) Target Price at $26.00

The Beauty Health Company (NASDAQ:SKINGet Rating) has been given a consensus rating of “Moderate Buy” by the twelve research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $26.00.

Several equities analysts have issued reports on SKIN shares. Piper Sandler decreased their price target on shares of Beauty Health from $26.00 to $24.00 in a research report on Wednesday, May 11th. DA Davidson decreased their price target on shares of Beauty Health from $35.00 to $24.00 in a research report on Wednesday, May 11th. Canaccord Genuity Group decreased their price objective on shares of Beauty Health from $27.00 to $22.00 in a research report on Wednesday, May 11th. Benchmark increased their price objective on shares of Beauty Health from $18.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, March 14th. Finally, JPMorgan Chase & Co. assumed coverage on shares of Beauty Health in a research report on Friday, March 11th. They set an “overweight” rating and a $24.00 price objective for the company.

Several hedge funds have recently made changes to their positions in SKIN. BlackRock Inc. increased its stake in shares of Beauty Health by 5.8% in the first quarter. BlackRock Inc. now owns 7,778,389 shares of the company’s stock worth $131,300,000 after purchasing an additional 423,084 shares in the last quarter. William Blair Investment Management LLC increased its stake in shares of Beauty Health by 232.2% in the fourth quarter. William Blair Investment Management LLC now owns 6,251,906 shares of the company’s stock worth $151,046,000 after purchasing an additional 4,370,217 shares in the last quarter. Invesco Ltd. increased its stake in shares of Beauty Health by 8.8% in the first quarter. Invesco Ltd. now owns 5,020,317 shares of the company’s stock worth $84,742,000 after purchasing an additional 407,849 shares in the last quarter. Luxor Capital Group LP increased its stake in shares of Beauty Health by 29.7% in the fourth quarter. Luxor Capital Group LP now owns 4,108,912 shares of the company’s stock worth $99,271,000 after purchasing an additional 941,138 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Beauty Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 2,394,159 shares of the company’s stock valued at $40,414,000 after acquiring an additional 125,195 shares during the period. Institutional investors own 72.01% of the company’s stock.

SKIN stock opened at $12.47 on Thursday. The company has a 50 day simple moving average of $12.90 and a 200 day simple moving average of $16.12. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of -3.67 and a beta of 1.71. Beauty Health has a 1 year low of $9.94 and a 1 year high of $30.17. The company has a debt-to-equity ratio of 2.14, a current ratio of 14.25 and a quick ratio of 13.57.

Beauty Health (NASDAQ:SKINGet Rating) last released its quarterly earnings data on Tuesday, May 10th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Beauty Health had a negative return on equity of 0.01% and a negative net margin of 117.84%. The company had revenue of $75.40 million for the quarter, compared to analyst estimates of $68.15 million. The company’s revenue for the quarter was up 58.7% on a year-over-year basis. On average, equities research analysts anticipate that Beauty Health will post 0.06 EPS for the current fiscal year.

Beauty Health Company Profile (Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.

Read More

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.